Purple Biotech Ltd.PPBTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+42.7%
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+42.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.9x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
202450.59%
20231.47%
2022-26.03%
2021-35.46%
2020-85.01%
20198.56%
201834.60%
2017-66.59%
2016-76.53%
201521.46%